Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $24.5000 (8.12%) ($22.1000 - $24.5200) on Tue. Dec. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 58 | Latest Price | $24.5000(8.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.825% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-9%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | 0 () | Intraday Trend | 9.2% | | | |
|
5 Day Moving Average | $23.11(6.01%) | 10 Day Moving Average | $22.8(7.46%) | 20 Day Moving Average | $22.61(8.36%) | To recent high | 0% | To recent low | 36.5% | Market Cap | $3.588b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |